Michael LinkAcademic Appointments
Appointment
Organization
Professor
Member
|
Honors & Awards
Title
Organization
Date(s)
Annual Memorial Lectureship
Pediatric Cancer Research Foundation
2004
Ben Abelson Memorial Visiting Professor
Washington University School of Medicine
2000
Alpha Omega Alpha
Alpha Omega Alpha
1974
Phi Beta Kappa
Phi Beta Kappa
1969
Administrative Appointments
Title
Organization
Start Year
End Year
Director, Center for Cancer and Blood Diseases
Lucile Packard Children's Hospital at Stanford
2002
-
Chief, Division of Pediatric Hematology/Oncology
Stanford University School of Medicine
2000
-
Lydia J. Lee Professor in Pediatric Cancer
Stanford University
2003
-
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
MD
Stanford University
Medicine
1974
AB
Columbia College
Political Science
1970
Research Interests
Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.
Publications
- Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM "Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease." J Clin Oncol 2007; 25: 3: 332-7 More »
- George TI, Jeng M, Berquist W, Cherry AM, Link MP, Arber DA "Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature." Pediatr Blood Cancer 2005; 44: 3: 270-6 More »
- Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H "Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate." J Clin Oncol 2005; 23: 9: 2004-11 More »
- Lieskovsky YE, Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP, Agarwal R "High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices." J Clin Oncol 2004; 22: 22: 4532-40 More »
- Spunt SL, Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP "Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group." Clin Cancer Res 2004; 10: 18 Pt 1: 6072-9 More »
160 publications: view full list
